The pathological significance of HRAS gene mutation in colorectal cancer patients in Erbil province

Salar Saadi Dizayee

doi:10.15218/zjms.2024.28

Authors

Salar Saadi Dizayee Department of Nursing, College of Nursing, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2024.28

Keywords:

HRAS gene, Mutation, Colorectal cancer, Pathology

Abstract

Background and objective: RAS gene mutations, including Harvey RAS, are a biomarker in studying many types of cancer, including colorectal cancer. Studying the molecular and mutations of the HRAS gene help in understanding the nature of the tumor and helps to formulate a suitable plan for prevention and treatment. The aim of the present study is to identify HRAS mutations among a sample of colorectal cancer.

Methods: The sample for the present study involved 20 Formalin fixed embedded tissue of colorectal carcinoma and 10 adjacent normal tissues were obtained from Rizgary Teaching Hospital in Erbil.

Results: The sample of the present study involved 20 patients (60% males and 40% females) with CRC. The mean age was 54.20 years, with an SD ±19.80. The study found a single HRAS mutation in the sample study. The size of the tumor mutated by HRAS is significantly different than other tumors (P = 0.009).

Conclusion: there was an HRAS mutation in a sample of colorectal cancers and the size of the tumor was different than other tumors in the study sample. Further studies needed about the mutation of the HRAS gene.

Metrics

Metrics Loading ...

References

Arnold M, Sierra MS, Laversanne, M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. BMJ 2017; 66(4):683–91. DOI: 10.1136/gutjnl-2015-310912.

Bray F, Colombet M, Mery L,Piñeros M, Znaor AZ, Zanetti R Ferlay J. International Agency for Research on Cancer. Cancer Incidence in Five Continents. WHO 2021; 166.

Lundberg I. Molecular understanding of KRAS-and –mutated colorectal cancer. Department of medical biosciences, pathology. New series No: 1885. Umeå University. Sweden; 2017. available at http://umu.diva-portal.org/.

Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021; 14(10):101174. DOI:10.1016/j.tranon.2021.101174.

Khalil K, Al-Hassawi B, Abdo J. Histopathological evaluation of colorectal carcinoma. DMJ 2018; 12(2):45–67.https://doi.org/10.31386/dmj.uod.18.12.2.5.

Demb J, EarlesA,Martínez ME, Bustamante R, Bryant A, Murphy JD, et al. Risk factors for colorectal cancer significantly vary by anatomic site. BMJ Open Gastro 2019; 6:e000313. doi:10.1136/bmjgast-2019-00031.

Baran B, MertOzupek N, YerliTetik N, Acar E, Bekcioglu O, Baskin Y. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterol Res 2018; 11(4):264–73. DOI: 10.14740/gr1062w

Imperial R, Ahmed Z, Toor O M, Erdoğan C, Khaliq A, Case P, et al. Comparative Proteogenomic Analysis of Right-Sided colon Cancer, Left-Sided colon Cancer and Rectal Cancer Reveals Distinct Mutational Profiles. Mol Cancer J 2018; 17(1):177–84. DOI:10.1186/s12943-018-0923-9.

Siegel R L, Miller K D, Goding Sauer A, Fedewa S A, Butterly LF, Anderson J C, et al. Colorectal Cancer Statistics 2020. CA A Cancer J Clin 2020; 70(3):145–64. https://doi.org/10.3322/caac.21601

Kuipers E J, Grady W M, Lieberman D, Seufferlein T, Sung J, BoelensVelde CJ, et al., Colorectal cancer. Nat Rev Dis Primers 2015; 1(15066). doi: 10.1038/nrdp.2015.65.

Whiffin N, Hosking FJ, Farrington SM, Palles C, Dobbins SE, Zgaga L, et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum Mol Genet 2014; 23(17):4729–37. DOI: 10.1093/hmg/ddu177

Lewandowska A, Rudzki G, Lewandowski T, tryjkowska-Góra A, Rudzki S. Title: Risk Factors for the Diagnosis ofColorectal Cancer. Cancer Control 2022; 29:1–15. DOI: 10.1177/10732748211056692.

Veettil S, Wong TY, Loo YS, Playdon MC, Lai NM, Giovannucci EL, et al. Role of Diet in Colorectal Cancer Incidence Umbrella Review of Meta-analyses of Prospective Observational Studies. JAMA Network Open 2021; 4(2):e2037341. doi:10.1001/jamanetworkopen.2020.37341

Sawicki T, RuszkowskaM, Danielewicz A, Niedzwiedzka E, Arłukowicz T, Przybyłowicz K. Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis Cancers. Cancers (Basel) 2021; 13(9):2025. https://doi.org/10.3390/cancers13092025.

Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiol Biomarkers Prev 2016; 25(7):1018–28. DOI: 10.1158/1055-9965.EPI-16-0121.

Silva E, Degreea M, Baima J, Barros J, Degreea M, Tanni E, et al. Risk factors for ulcerative colitis-associated colorectal cancer A retrospective cohort study. Medicine (Baltimore) 2020; 99(32): e21686. DOI: 10.1097/MD.0000000000021686

Sameer AS. Colorectal Cancer: Molecular Mutations and Polymorphisms. Front Oncol 2013; 3(114):1–8. https://doi.org/10.3389/fonc.2013.00114.

Muñoz-Maldonado C, Zimmer Y, Medova M A. Comparative Analysis of Individual RAS Mutations in Cancer Biology. Front Oncol 2019; 18(9):1088–96. DOI: 10.3389/fonc.2019.01088

Li S, Balmain A, Counter CM. A model for RAS mutation patterns in cancers: finding the sweet spot. Nat Rev Cancer 2018; 18(12):767–77. DOI: 10.1038/s41568-018-0076-6

Leong A, Zhuang Z. The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment. Pathobiology 2011; 78(2):99–114. doi: 10.1159/000292644.

Matias-Guiu X,Stanta G, Carneiro F, Ryska, Hoefler G, Moch H. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology. Virchows Arch 2020; 476(4):491–7. doi: 10.1007/s00428-020-02757-0.

Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FB, Verhoef S, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer 2006; 94(2):333–7. doi: 10.1038/sj.bjc.6602889

TolJ, Dijkstra JR, Vink-Börger ME, Nagtegaal ID, Punt CJ,Krieken JH, et al. High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue. J Cell Mol Med 2010; 14(8):2122–31. DOI: 10.1111/j.1582-4934.2009.00788.x

Homady MH, Juma ASM, UbeidMH, Salih TS, Al-Jubori MM. Age and Gender in Relation to Colorectal Cancer in Najef Province: A Histopathological Study. Acta Scientific Pharmaceutical Sciences 2021; 2(1):2768–87. DOI: 10.31579/2768-0487/006.

Chang HC, Horng JT, Lin W, Lai HW, Chang CW, Chen T. Evaluation of the Appropriate Age Range of Colorectal Cancer Screening Based on the Changing Epidemiology in the Past 20 Years in Taiwan. ISRN 2012; 2012:960867. doi:10.5402/2012/960867.

White A, Ironmonger L, Steele R, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 2018; 18(1):906. doi: 10.1186/s12885-018-4786-7.

Ahmed HG, Alawad GM, Alharbi SH, Alreshidi FS, Alotaibi AD, Alshaikh AA. Histopathological pattern of colorectal cancer in relation to age and gender in northern Saudi Arabia. J Cancer Prev Curr Res 2017; 8(3):283‒7. DOI.10.15406/jcpcr.2017.08.00281

Ye Z, Qiu M, Tang T, Wang F, Zhou Y, lei M, et al. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinic pathological characteristics and prognosis. Cancer Med 2020; 9:745–56. DOI: 10.1002/cam4.2727.

Chang YY, Lin PC, Lin HH, Lin J, Chen W, Jiang J, et al. Mutation spectra of RAS gene family in colorectal cancer. Am J Surg 2016; 212(3):537–44.e3. DOI: 10.1016/j.amjsurg.2016.02.013

Maffeis V, Nicolè L, Cappellesso R. RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer. Front Oncol 2019; 9:1255–72. doi: 10.3389/fonc.2019.01255

Fernández-Medarde A, Santos E. Ras in Cancer and Developmental Diseases. Genes Cancer 2011; 2(3):344–58. doi: 10.1177/1947601911411084

Serebriiskii LG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, et al. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nat Commun 2019; 10:3722. https://doi.org/10.1038/s41467-019-11530-0

Feng J, Hua F, Shuo R, Chongfeng G, Huimian X, Nakajima T, et al. Upregulation of non-mutated H-ras and its upstream and downstream signaling proteins in colorectal cancer. Oncol Rep 2001; 8(6):1409–13. https://doi.org/10.3892/or.8.6.1409

Abudabous A, Drah M, Aldehmani M, Parker I, AL Qawi O. KRAS mutations in patients with colorectal cancer in Libya. Mol Clin Oncol 2021; 15(4):197–203. DOI: 10.3892/mco.2021.2359

Alzahrani SM, Al Doghaither H, Al Ghafari A. General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol 2021; 15(6):271–9. DOI: 10.3892/mco.2021.2433.

Xu Y, Chen Y, Long C, Zhong H, Liang F, Huang L, et al. Preoperative predictor of Lymph Node Metastasis in colon cancer. Front Oncol 2021. https://doi.org/10.3389/fonc.2021.667477